| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |